[ad_1] The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer. The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter. Revenue for the three months ended Sept. 30 rose 15.9% to…
[ad_1] UBS thinks UnitedHealth is an essential portfolio holding trading at a discount. The firm upgraded shares of the health care giant to buy from neutral and raised its target price to $640 from $520. UBS’ forecast implies roughly 19% upside from Friday’s $539.40 close. Analyst AJ Rice labeled the stock as “a core holding…
[ad_1] Traders work at the post where UnitedHealth Group is traded on the floor of the New York Stock Exchange. Brendan McDermid | Reuters UnitedHealth Group‘s (UNH) quality quarterly results Friday are a good sign for the broader health-care landscape, CNBC’s Jim Cramer said. The managed-care giant earned an adjusted $6.56 per share on revenues…
[ad_1] It’s taken some patience. But shares of this company finally broke through $500 each in Friday trading, so we’re ringing the register. [ad_2] Source link
[ad_1] There’s Eli Lilly (LLY), and then there’s everybody else. That’s a simple way to describe the performance of the Club’s health-care holdings so far this year, in what’s been a challenging period for the industry overall. Of the 11 market sectors year to date, health care is the fourth worth-worst performer, falling 4%, followed…
[ad_1] A CVS location in New York, US, on Thursday, Feb. 9, 2023. Stephanie Keith | Bloomberg | Getty Images Shares of CVS Health plunged 9% on Thursday after Blue Shield of California said it will drop the company’s pharmacy benefit management services and instead partner with Mark Cuban’s Cost Plus Drugs company and Amazon…
[ad_1] When Dr. Tra’chella Johnson Foy greets her patients, she sits across from them facing away from the computer in the exam room. Then, she pulls out her phone, and asks for permission to record the appointment. “It listens in on our visit so I can pay more attention to you,” explains Foy, a family…
[ad_1] Humana (HUM) reported second-quarter results Wednesday that were much better than feared, sending its stock price soaring and giving us the confidence to stick with the jilted health insurer. Revenue for the three months ended June 30 rose 13% year-over-year, to $26.75 billion, exceeding analysts’ estimates of $26.23 billion, according to Refinitiv. Adjusted earnings-per-share…
[ad_1] A Humana office in Louisville, Kentucky, July 31, 2023. Jon Cherry | Bloomberg | Getty Images Humana shares rose Wednesday after the health insurer said medical costs came in lower than expected during its second-quarter earnings report. The results ease investor concerns two months after Humana and rival UnitedHealth Group warned that a surge…
[ad_1] Johnson & Johnson on Thursday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations, and lifted its full-year guidance as sales from the company’s medtech business jumped. The medtech division provides devices for surgeries, orthopedics and vision. The company is benefitting from a rebound in demand for non-urgent surgeries among older adults,…
